Motegrity

Chemical Nameprucalopride
Dosage FormTablet (oral; 1 mg, 2 mg)
Drug ClassReceptor agonists
SystemDigestive
CompanyShire LLC
Approval Year2018

Indication

  • To treat chronic idiopathic constipation in adults.
Last updated on 11/5/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Motegrity (Prucalopride) Prescribing Information 2018Shire LLC, Lexington, MA
Document TitleYearSource
Efficacy of drugs in chronic idiopathic constipation: A systematic review and network meta-analysis. 2019The Lancet. Gastroenterology & Hepatology
Document TitleYearSource
Clinical practice guidelines from the French National Society of Coloproctology in treating chronic constipation. 2018European Journal of Gastroenterology & Hepatology